… We have previously demonstrated that for patients with symptomatic endometriosis,
GnRH agonist therapy can be safely prolonged for up to 12 months with the addition of an …

… no additional therapy in patients with endometriosis prior to … term GnRH agonists prior to
IVF/ICSI in women with endometriosis… away from the use of GnRH agonists. Further high‐quality …

… -treatment with GnRH analogues before an IVF cycle in endometriosis patients to improve
the … GnRHa therapy or other alternatives on infertility management of endometriosis patients. …

… has shown that in female patients with stage III or IV endometriosis, the efficacy of GnRH-a
administered 3–5 days postoperatively was equivalent to that of GnRH-a administered on …

… without influencing bone-mineral density, we studied the effects of GnRH agonist … of
gonadotropin-releasing hormone agonist on the bone mineral density of patients with endometriosis. …

… combination with a GnRH agonist to limit these side-effects, while still allowing regression of
endometriotic lesions. … Stage IV patients could not be treated, as experienced before using a …

… In a small study, a GnRH agonist resulted in a similar shift in lipid levels, with a mean increase
in … women with endometriosis were similar to those of patients in epidemiologic studies of …

… contraceptives, as well as GnRH agonist (GnRH-a) have been usually … GnRH-a is frequently
used in endometriosis patients … the rate of endometriosis recurrence in patients with different …

… In infertile patients with endometriosis, laparoscopic surgery can completely remove the
lesion tissue. The operation time is relatively short, which is beneficial to the recovery of …

… Any potential benefits of GnRH agonists in infertile patients with endometriosis may be best
realized … after prolonged GnRH agonist therapy has benefit in patients with endometriosis. …